IDSA advanced global health priorities at the 72^nd World Health Assembly, May 20-28, in Geneva. IDSA presented statements during floor debate on the issues of public health emergency preparedness response, climate change and health, and follow up on United Nations high level meetings on antimicrobial resistance and eliminating tuberculosis. 

As 2020 presidential campaigns gather speed, IDSA, HIVMA, and PIDS are asking all candidates to commit to policies that will address serious infectious diseases threats and accelerate progress in responding to infectious diseases in the U.S. and globally.

Learn about the progress IDSA has made in its ongoing efforts to achieve and maintain inclusion, diversity, access and equity in the Society, as well as the work that is still to come, in this article by Drs. Jasmine Marcelin and Ravina Kullar.

During a recent congressional briefing, “The Essential Role of Diagnostics in Outbreak Detection and Response,” IDSA Diagnostics Committee Chair Kimberly Hanson, MD, shared her laboratory’s case of a Zika index patient and how various types of diagnostic testing contributed to diagnosis and treatment.

Modern Healthcare spoke with IDSA Board Member Helen Boucher, MD, FIDSA on the rate at which pathogens are growing progressively resistant to antibiotics, bringing the world dangerously close to a “post-antibiotic” era.